169 related articles for article (PubMed ID: 29024461)
1. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
Rawstron AC; Kreuzer KA; Soosapilla A; Spacek M; Stehlikova O; Gambell P; McIver-Brown N; Villamor N; Psarra K; Arroz M; Milani R; de la Serna J; Cedena MT; Jaksic O; Nomdedeu J; Moreno C; Rigolin GM; Cuneo A; Johansen P; Johnsen HE; Rosenquist R; Niemann CU; Kern W; Westerman D; Trneny M; Mulligan S; Doubek M; Pospisilova S; Hillmen P; Oscier D; Hallek M; Ghia P; Montserrat E
Cytometry B Clin Cytom; 2018 Jan; 94(1):121-128. PubMed ID: 29024461
[TBL] [Abstract][Full Text] [Related]
2. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract][Full Text] [Related]
3. ROR1 expression in mature B lymphoid neoplasms by flow cytometry.
de Sousa FA; Millan NM; Correia RP; da Costa Vaz A; Schimidell D; Miyamoto PC; Passaro MS; Nogueira BG; Souto EX; Bacal NS; Bento LC
Cytometry B Clin Cytom; 2024 Jan; 106(1):74-81. PubMed ID: 38273649
[TBL] [Abstract][Full Text] [Related]
4. Performance of a novel eight-color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia.
Chen X; Chen X; Zhao S; Shi Y; Zhang N; Guo Z; Qiao C; Jin H; Zhu L; Zhu H; Li J; Wu Y
Cytometry B Clin Cytom; 2024 Mar; ():. PubMed ID: 38535092
[TBL] [Abstract][Full Text] [Related]
5. What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
D'Arena G; Vitale C; Pietrantuono G; Villani O; Mansueto G; D'Auria F; Statuto T; D'Agostino S; Sabetta R; Tarasco A; Innocenti I; Autore F; Fresa A; Valvano L; Tomasso A; Cafaro L; Lamorte D; Laurenti L
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275909
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data.
Gross Z; Veyrat-Masson R; Grange B; Huet S; Verney A; Traverse-Glehen A; Ruminy P; Baseggio L
Hematol Oncol; 2024 Jan; 42(1):e3245. PubMed ID: 38287532
[TBL] [Abstract][Full Text] [Related]
7. Transient disappearance of CD19
Barnabei R; Di Michele G; Cellini A; Amicosante G; Perilli M; Bellio P; Piccirilli A; Celenza G
Clin Case Rep; 2021 Jun; 9(6):e04238. PubMed ID: 34188925
[TBL] [Abstract][Full Text] [Related]
8. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating M; Montserrat E; Chiorazzi N; Stilgenbauer S; Rai KR; Byrd JC; Eichhorst B; O'Brien S; Robak T; Seymour JF; Kipps TJ
Blood; 2018 Jun; 131(25):2745-2760. PubMed ID: 29540348
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotyping of Chronic Lymphocytic Leukemia.
Falay M; Özet G
Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands.
Kersting S; Neppelenbroek SIM; Visser HPJ; van Gelder M; Levin MD; Mous R; Posthuma W; van der Straaten HM; Kater AP
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):52-57. PubMed ID: 29097160
[TBL] [Abstract][Full Text] [Related]
11. Imaging flow cytometry to assess chromosomal abnormalities in chronic lymphocytic leukaemia.
Hui H; Fuller KA; Chuah H; Liang J; Sidiqi H; Radeski D; Erber WN
Methods; 2018 Feb; 134-135():32-40. PubMed ID: 29155042
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.
Rodríguez-Vicente AE; Bikos V; Hernández-Sánchez M; Malcikova J; Hernández-Rivas JM; Pospisilova S
Oncotarget; 2017 Sep; 8(41):71234-71248. PubMed ID: 29050359
[TBL] [Abstract][Full Text] [Related]
13. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.
Salem DA; Stetler-Stevenson M
Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
[TBL] [Abstract][Full Text] [Related]
14. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
17. CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic Leukemia.
Afacan-Öztürk HB; Falay M; Albayrak M; Yıldız A; Öztürk ҪP; Maral S; Özet G
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868852
[TBL] [Abstract][Full Text] [Related]
18. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Malcikova J; Tausch E; Rossi D; Sutton LA; Soussi T; Zenz T; Kater AP; Niemann CU; Gonzalez D; Davi F; Gonzalez Diaz M; Moreno C; Gaidano G; Stamatopoulos K; Rosenquist R; Stilgenbauer S; Ghia P; Pospisilova S;
Leukemia; 2018 May; 32(5):1070-1080. PubMed ID: 29467486
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatments.
Ghia P; Rawstron A
Leukemia; 2018 Jun; 32(6):1307-1316. PubMed ID: 29700386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
